RESPIRATORY INFECTION
Clinical trials for RESPIRATORY INFECTION explained in plain language.
Never miss a new study
Get alerted when new RESPIRATORY INFECTION trials appear
Sign up with your email to follow new studies for RESPIRATORY INFECTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug AV-001 tested for severe pneumonia in hospital patients
Disease control Recruiting nowThis study tests an investigational drug called AV-001 in people hospitalized with pneumonia caused by COVID-19 or other respiratory infections. The goal is to see if AV-001 is safe and helps patients recover faster when added to standard care. About 120 participants will receive…
Matched conditions: RESPIRATORY INFECTION
Phase: PHASE2 • Sponsor: Vasomune Therapeutics, Inc. • Aim: Disease control
Last updated May 26, 2026 07:24 UTC
-
New test aims to spot coronaviruses faster and more accurately
Diagnosis Recruiting nowThis study evaluates a new test called the BioFire Emerging Coronavirus Panel, which looks for coronaviruses in nose swab samples. Researchers will check how well the test detects these viruses compared to standard methods. About 1,500 leftover swab samples from routine care will…
Matched conditions: RESPIRATORY INFECTION
Sponsor: BioFire Defense LLC • Aim: Diagnosis
Last updated May 26, 2026 07:52 UTC
-
New pill aims to stop recurring chest infections in adults
Prevention Recruiting nowThis study tests whether Buccalin tablets can reduce the number of lower respiratory infections (like bronchitis) in adults who get them often. 240 participants will take either Buccalin or a placebo for 12 months. The goal is to see if Buccalin prevents future infections safely.
Matched conditions: RESPIRATORY INFECTION
Phase: PHASE4 • Sponsor: Laboratorio Farmaceutico SIT srl • Aim: Prevention
Last updated May 26, 2026 07:52 UTC